Depression and Apathy After Transient Ischemic Attack or Minor Stroke: Prevalence, Evolution and Predictors.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
07 11 2019
07 11 2019
Historique:
received:
28
09
2018
accepted:
22
10
2019
entrez:
9
11
2019
pubmed:
9
11
2019
medline:
5
11
2020
Statut:
epublish
Résumé
Few previous studies have focused on affective impairment after transient ischemic attack (TIA) and/or minor stroke. The aim was to establish the prevalence, evolution and predictors of post-stroke depression (PSD) and post-stroke apathy (PSA) over a 12-month follow-up period. We prospectively included TIA and minor stroke patients (NIHSS ≤4) who had undergone magnetic resonance imaging <7 days. PSD was diagnosed according to DSM-5 criteria and PSA was defined based on an Apathy Evaluation Scale (AES-C) score of ≥37. Clinical and neuroimaging variables (presence and patterns of lesion, cerebral bleeds and white matter disease) were analysed in order to find potential predictors for PSD and PSA. Follow-up was performed at 10 days and after 2, 6, 9 and 12 months. 82 patients were included (mean 66.4 [standard deviation11.0] years) of whom 70 completed the follow-up. At 10 days, 36 (43.9%) and 28 (34.1%) patients respectively were diagnosed with PSD and PSA. At 12 months, 25 of 70 (35.7%) patients still had PSA, but only 6 of 70 (8.6%) had PSD. Beck Depression Inventory-II score, mini mental state examination (MMSE) and a previous history of depression or anxiety were predictors for PSD. While MMSE score, The Montgomery Asberg Depression Rating Scale and having previously suffered a stroke were also risk factors for PSA. Acute basal ganglia lesion and periventricular leukoaraiosis were associated with PSA while deep leukorariosis with PSD. Despite the presence of few or only transient symptoms, PSD and PSA frequent appear early after TIA and minor stroke. Unlike PSD, apathy tends to persist during follow-up.
Identifiants
pubmed: 31700058
doi: 10.1038/s41598-019-52721-5
pii: 10.1038/s41598-019-52721-5
pmc: PMC6838079
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
16248Références
Stroke. 2011 Sep;42(9):2672-713
pubmed: 21778438
J Psychosom Res. 2009 Oct;67(4):325-32
pubmed: 19773025
Cerebrovasc Dis. 2013;35(1):23-39
pubmed: 23428994
Lancet Neurol. 2017 Apr;16(4):301-310
pubmed: 28238711
Stroke. 2012 Apr;43(4):1000-5
pubmed: 22363064
Rev Neurol. 2008 Feb 1-15;46(3):147-52
pubmed: 18297621
Int J Geriatr Psychiatry. 2007 Oct;22(10):1046-51
pubmed: 17702056
Psychol Med. 2005 Dec;35(12):1707-16
pubmed: 16202190
Nat Rev Neurol. 2016 May;12(5):269-80
pubmed: 27063107
J Geriatr Psychiatry Neurol. 2016 Jul;29(4):171-6
pubmed: 27056065
J Affect Disord. 2013 May;147(1-3):186-91
pubmed: 23167974
BMC Neurol. 2015 Mar 15;15:36
pubmed: 25880287
Stroke. 2017 Feb;48(2):e30-e43
pubmed: 27932603
Psychogeriatrics. 2011 Mar;11(1):68-76
pubmed: 21447112
Md State Med J. 1965 Feb;14:61-5
pubmed: 14258950
Stroke. 2009 Dec;40(12):3828-33
pubmed: 19797698
Am J Geriatr Psychiatry. 2009 Jul;17(7):542-55
pubmed: 19546653
J Am Heart Assoc. 2015 May 13;4(5):
pubmed: 25971438
Stroke. 2005 Oct;36(10):2296-301
pubmed: 16179565
Int J Rehabil Res. 2008 Dec;31(4):321-6
pubmed: 19008681
Stroke. 2009 Jun;40(6):2276-93
pubmed: 19423857
Heart Lung. 2009 Mar-Apr;38(2):151-62
pubmed: 19254633
Cerebrovasc Dis. 2008;26(6):592-9
pubmed: 18946214
Stroke Res Treat. 2013;2013:862978
pubmed: 23533964
Stroke. 2011 Sep;42(9):2443-6
pubmed: 21757672
Stroke. 2013 Mar;44(3):851-60
pubmed: 23362076
Cerebrovasc Dis. 2013;35(6):507-13
pubmed: 23751773
Eur J Neurol. 2012 Mar;19(3):517-21
pubmed: 22175796
Stroke. 2014 Jan;45(1):77-81
pubmed: 24178917
J Neurol Neurosurg Psychiatry. 2014 Feb;85(2):198-206
pubmed: 23385849
Ann Intern Med. 2007 Oct 16;147(8):W163-94
pubmed: 17938389
Semin Clin Neuropsychiatry. 1996 Oct;1(4):304-314
pubmed: 10320433
Eur J Neurol. 2012 Feb;19(2):291-7
pubmed: 21895880
Stroke. 2009 Jan;40(1):94-9
pubmed: 19008468
BMC Psychiatry. 2013 Jun 05;13:164
pubmed: 23738569
Br J Psychiatry. 1979 Apr;134:382-9
pubmed: 444788
Stroke. 2016 Mar;47(3):726-31
pubmed: 26846862
Eur J Neurol. 2011 Jan;18(1):121-8
pubmed: 20500525
Cerebrovasc Dis. 2013;35(6):566-71
pubmed: 23838825
Eur J Neurol. 2014 Oct;21(10):1258-67
pubmed: 24861479
PLoS One. 2017 May 11;12(5):e0176943
pubmed: 28493898
Cerebrovasc Dis. 2009;28(6):551-7
pubmed: 19844094
Can J Psychiatry. 2010 Jun;55(6):350-4
pubmed: 20540829
Rev Neurol. 2004 Nov 16-30;39(10):915-23
pubmed: 15573305
Int J Clin Exp Med. 2015 Aug 15;8(8):14119-22
pubmed: 26550380
Br J Psychiatry. 2013 Jan;202(1):14-21
pubmed: 23284148
Brain. 2015 Dec;138(Pt 12):3803-15
pubmed: 26490330
Dement Neuropsychol. 2012 Jul-Sep;6(3):152-157
pubmed: 29213789
Medicine (Baltimore). 2016 Nov;95(45):e5349
pubmed: 27828858
Cochrane Database Syst Rev. 2008 Oct 08;(4):CD003437
pubmed: 18843644
Stroke. 2009 Oct;40(10):3299-307
pubmed: 19713543
Stroke. 2017 Dec;48(12):3323-3328
pubmed: 29158448
J Geriatr Psychiatry Neurol. 2014 Sep;27(3):147-58
pubmed: 24713406
Stroke. 1993 Jan;24(1):35-41
pubmed: 7678184
Depress Res Treat. 2011;2011:893905
pubmed: 21747995
Stroke. 2005 Jun;36(6):1330-40
pubmed: 15879342